Drug intelligence / Profile preview

STAG1 molecular glue

Development stage
Preclinical
Lead developer
SyntheX
Modality
Molecular Glues → Targeted Protein Degraders (TPDs) → Small Molecules
01

Overview

SyntheX Labs is developing a small-molecule molecular glue targeting STAG1 for the treatment of cancer. Discovered using the company's proprietary ToRNeDO platform, this program leverages the concept of synthetic lethality. STAG1 is a paralog of STAG2, both of which are components of the cohesin complex. In many cancers, STAG2 is mutated or lost; research indicates that these STAG2-deficient cells become uniquely dependent on STAG1 for survival. By promoting the degradation or functional modulation of STAG1 through a molecular glue mechanism, the drug aims to selectively kill STAG2-deficient tumor cells while sparing healthy tissue. The program is currently in the screening and discovery phase.

Other names
STAG1 molecular glue degraderSTAG-1 molecular glue degraderSTAG 1 molecular glue degraderDigitoid Synthex STAG1 program
02

Targets

PMEPA1 (Prostate transmembrane protein, androgen induced 1)

Beyond the preview

Go deeper on STAG1 molecular glue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STAG1 molecular glue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call